Autobio Diagnostics Co., Ltd.

Shanghai Stock Exchange 603658.SS

Autobio Diagnostics Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2023: 14.26%

Autobio Diagnostics Co., Ltd. Return on Equity (ROE) is 14.26% for the year ending December 31, 2023, a -4.92% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

Autobio Diagnostics Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2022 was 15.00%, a 12.11% change year over year.
Autobio Diagnostics Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2021 was 13.38%, a 15.90% change year over year.
Autobio Diagnostics Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2020 was 11.54%, a -61.87% change year over year.
Autobio Diagnostics Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2019 was 30.28%, a 3.80% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

Shanghai Stock Exchange: 603658.SS

Autobio Diagnostics Co., Ltd.

CEO	Mr. Rui Kuan Fang
IPO Date	Sept. 2, 2016
Location	China
Headquarters	No. 199, 15th Avenue
Employees	5,539
Sector	Health Care
Industries Biotechnology Medical Instruments Pharmaceuticals

Description

Autobio Diagnostics Co., Ltd. engages in the research and development, production, and distribution of clinical diagnostic products. It develops immunoassay, biochemistry, microbiology, and IVD reagents; and instruments, such as automation and semi-automation systems, as well as medical laboratory solutions. The company's immunoassay products AutoLumo A2000 Plus, an automatic Chemiluminescence immunoassay analyzer; automatic microplate chemiluminescent enzyme immunoassay; and LUmo luminometers, PHOmo microplate readers, and iWO microplate washers. Its microbiology products comprise automated blood culture systems; blood culture bottles; AUTOMIC strips; and mycoplasma IES. The company was formerly known as Lifeclone Diagnostics Co., Ltd. and changed its name to Autobio Diagnostics Co., Ltd. in 2003. Autobio Diagnostics Co., Ltd. was founded in 1998 and is based in Zhengzhou, China. Autobio Diagnostics Co., Ltd. is a subsidiary of Zhengzhou Auto Industrial Co., Ltd.

Key trends

Past 5 years